A
10b5-1 Plan
$ Value
$42K
Shares
2,631
Price
$16
Filed
Mar 12
Insider
Name
Farquhar John C.M.
Title
Chief Executive Officer
CIK
0001900415
Roles
Director
Officer
Transaction Details
Transaction Date
2026-03-06
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
594,287
Footnotes
These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c). | The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
Filing Info
Farquhar John C.M.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-10 | HTFL | ▼ | $603K |
| 2026-03-18 | HTFL | ▼ | $243K |
| 2026-03-10 | HTFL | ▼ | $291K |
| 2026-03-06 | HTFL | A | $42K |
| 2026-02-10 | HTFL | ▼ | $620K |
| 2026-02-06 | HTFL | F | $43K |
| 2026-02-06 | HTFL | A | $0 |
| 2026-02-06 | HTFL | A | $0 |
| 2025-11-07 | HTFL | F | $44K |
| 2025-08-07 | HTFL | A | $0 |
Other Insiders at HTFL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BARABE TIMOTHY C | — | — | 2026-03-11 |
| HealthCor Partners Management LP | — | — | 2026-03-24 |
| Lightcap Jeffrey C | — | — | 2026-03-24 |
|
Rogers Campbell
Chief Medical Officer
|
— | $4.8M | 2026-04-01 |
| Bain Capital Life Sciences Investors, LLC | — | $56.1M | 2026-02-04 |
| Cullivan Julie A | — | $447K | 2026-03-05 |
|
Farquhar John C.M.
Chief Executive Officer
|
— | $1.8M | 2026-04-10 |
|
Jones Marie L.
Chief Accounting Officer, VP
|
— | — | 2026-02-06 |
|
Verghese Vikram
Chief Financial Officer
|
— | — | 2026-02-06 |